03 Slow Metabolizer‘s Dilemma: CYP1A2 CC and Heart Risk

The email came from a stranger. Subject line: “My son died. He drank energy drinks. Can you help me understand why?” I stared at it for a full minute. My coffee was on the desk, half‑drunk, the surface of the liquid still rippling from where I’d set down the mug too hard. I didn’t open it right away. I opened it three hours later, after I’d finished my morning cupping and walked Espresso around the block.

The mother’s name was Denise. Her son, Tyler, was seventeen. He played football. He was six feet tall, two hundred pounds, no known health problems. On a Friday night in March 2025, he drank two cans of a popular energy drink—each can labeled 200 mg of caffeine—while studying for finals. He went to bed around midnight. His heart stopped before morning.

The medical examiner found no structural abnormalities. No drugs. No alcohol. The cause of death: cardiac arrhythmia, probably triggered by caffeine. Denise had never heard of CYP1A2. She didn’t know that some people break down caffeine slowly. She didn’t know that Tyler might have been one of them.

I closed the email. My hand was shaking. Not from caffeine—I’d only had one cup that morning. From something else.

The Half‑Life Tracker doesn’t measure genetics. But it can show you the range.

Let me explain what Denise should have been told.

Your liver processes caffeine using an enzyme called cytochrome P450 1A2, or CYP1A2 for short. This enzyme is encoded by the CYP1A2 gene. The gene comes in different versions. The most common variant is a single nucleotide polymorphism—a single letter change in your DNA—at position rs762551.

If you have the A version of that SNP, you’re likely a “fast metabolizer.” Your liver clears caffeine quickly, with a half‑life of two to four hours. If you have the C version, you’re likely a “slow metabolizer.” Your half‑life can stretch to six, eight, even ten hours.

About 35-45% of people of European descent carry at least one C allele. Among African and Asian populations, the percentage is higher. Many of them don’t know it.

The Caffeine Calculator can estimate your safe daily limit based on your self‑reported caffeine sensitivity.

I remember the first time I saw the research linking slow metabolism to heart risk. It was 2019, a paper in the Journal of the American Heart Association. The researchers followed 4,000 adults for seven years. They genotyped everyone for CYP1A2. Then they tracked coffee consumption and cardiovascular events.

The fast metabolizers who drank two or more cups a day had no increased risk of heart attack or hypertension. The slow metabolizers who drank the same amount had a 36% higher risk. Thirty‑six percent. Not a rounding error.

I read that paper sitting in a café on Capitol Hill, my notebook open, a latte cooling beside me. I read it twice. Then I called my doctor and asked for a genetic test. She said no. “Not medically necessary,” she said. I didn’t push. I just started tracking my own half‑life by feel.

Let me tell you about a client I worked with later, after I left the coffee industry and started consulting. His name was Marcus. He was forty‑two, a software engineer, fit, no family history of heart disease. He drank about 400 mg of caffeine a day—three cups of coffee, sometimes an energy drink in the afternoon. He started having palpitations. Fluttering in his chest, mostly in the evening, after dinner.

His doctor ran an EKG. Normal. Put him on a Holter monitor for 24 hours. The monitor caught occasional premature ventricular contractions—PVCs, extra heartbeats. The doctor said they were benign. “Lots of people have them,” he said. “Cut back on caffeine.”

Marcus cut back to 200 mg a day. The palpitations continued. He cut back to 100 mg. They stopped. He told me this story over Zoom, rubbing his chest as he spoke, like he was trying to soothe something that wasn’t there anymore.

“Do you know your CYP1A2 status?” I asked him.

“No,” he said. “But I don’t need a test to tell me I’m a slow metabolizer. My body already did.”

The Half‑Life Tracker can’t diagnose you. But it can help you notice patterns.

I never got the genetic test. I don’t know if I have one C allele or two. But I know that 200 mg of caffeine at 9 AM leaves me feeling wired at 3 PM. I know that 300 mg in a day makes my eyelid twitch. I know that 400 mg makes me feel like my heart is a bird trapped in a cage.

I’m probably a slow metabolizer. Denise’s son might have been too.

The connection between slow caffeine metabolism and heart risk is dose‑dependent. A small study from 2022 gave slow metabolizers 100 mg of caffeine and measured their blood pressure two hours later. The increase was modest—about 5 mmHg systolic. Not dangerous. The same group took 300 mg. Their systolic pressure jumped by 15 mmHg, and stayed elevated for six hours. Fifteen millimeters of mercury is the difference between normal blood pressure and stage one hypertension.

Now imagine doing that every day for years. Imagine doing that as a teenager, when your heart is still developing. Imagine doing that with undiagnosed long QT syndrome or another channelopathy. The risk multiplies.

The Energy Drink Comparator can show you how different products stack up.

I don’t know if Tyler’s death could have been prevented. Neither does his mother. But she asked me to do something with her story. So I’m doing this.

If you have a family history of early heart disease, if you feel palpitations after coffee, if you notice that a single cup in the afternoon ruins your sleep, consider that you might be a slow metabolizer. You don’t need a genetic test to experiment. Cut your intake in half for a week. See how you feel. Watch your resting heart rate. Watch your sleep.

The Half‑Life Tracker can help you measure the difference.

I think about Tyler sometimes, late at night, when Espresso is purring on my lap and Sam is reading beside me. I think about his mother, writing that email, her hands probably shaking too. I think about the fact that she had to search for answers on her own. That no one had told her about CYP1A2. That no one had told her son.

That’s why I write this.